Persistent vascular collagen accumulation alters hemodynamic recovery from chronic hypoxia

Journal of Biomechanics

Volumn 45, Issue 5, 2012, Pages 799-804

  Tabima, Diana M ^a   Roldan Alzate, Alejandro ^a   Wang, Zhijie ^a   Hacker, Timothy A ^b   Molthen, Robert C ^c   Chesler, Naomi C ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Collagen; Pulmonary artery stiffness; Pulmonary hemodynamics; Pulmonary hypertension; Pulmonary vascular impedance

Indexed keywords

CARDIAC OUTPUT; CHARACTERISTIC IMPEDANCE; CHRONIC HYPOXIAS; COLLAGEN ACCUMULATION; HIGH STRAINS; INNER DIAMETERS; MICROCOMPUTED TOMOGRAPHY; PULMONARY ARTERIAL HYPERTENSION; PULMONARY ARTERY; PULMONARY HYPERTENSION; PULSE WAVE VELOCITY; RIGHT VENTRICULAR; TYPE I COLLAGEN; WAVE REFLECTIONS; WILD TYPES;

BLOOD PRESSURE; COLLAGEN; COMPUTERIZED TOMOGRAPHY; MAMMALS; RECOVERY; STIFFNESS;

HEMODYNAMICS;

COLLAGEN;

ANIMAL TISSUE; ARTERIAL STIFFNESS; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; GENOTYPE; HEART OUTPUT; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE FUNCTION; HOMOZYGOSITY; HYPOXIA; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; WILD TYPE;

ANIMALS; ANOXIA; BLOOD FLOW VELOCITY; CARDIAC OUTPUT; COLLAGEN TYPE I; FEMALE; HEMODYNAMICS; HYPERTENSION, PULMONARY; LUNG; MALE; MICE; PULMONARY ARTERY; PULMONARY CIRCULATION; VASCULAR RESISTANCE; VENTRICULAR FUNCTION, RIGHT;

EID: 84857640634     PISSN: 00219290     EISSN: 18732380     Source Type: Journal    
DOI: 10.1016/j.jbiomech.2011.11.020     Document Type: Article

References (35)

1. Coghlan J.G., Mukerjee D. The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology. Current Opinion in Rheumatology 2001, 13(6):495-499.
2. Cotran R.S., Kuman V., et al. Robbins Pathologic Basis of Disease 1999, W.B. Saunders, Philadelphia.
3. Edwards C.A., O'Brien W.D. Modified assay for determination of hydroxyproline in a tissue hydrolyzate. Clinica Chimica Acta; International Journal of Clinical Chemistry 1980, 104(2):161-167.
4. Faber J.E., Szymeczek C.L., et al. Alpha1-adrenoceptor-dependent vascular hypertrophy and remodeling in murine hypoxic pulmonary hypertension. American Journal of Physiology Heart and Circulatory Physiology 2007, 292(5):H2316-2323.
5. Fagan K.A., Badesch D.B. Pulmonary hypertension associated with connective tissue disease. Progress in Cardiovascular Diseases 2002, 45(3):225-234.
6. Gan C.T., Lankhaar J.W., et al. Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension. Chest 2007, 132(6):1906-1912.
7. Hemnes A.R., Champion H.C. Right heart function and haemodynamics in pulmonary hypertension. International Journal of Clinical PracticeSupplement 2008, 62(160):11-19.
8. Hoyt, R.F., J.V. Hawkins, et al. (2007). Mouse Physiology. The Mouse in Biomedical Research: Normative Biology, Husbandry and Models. Fox, J.G., Barthold, S.W., Davisson, M.T., et al. (Eds.).Academic Press, San Diego, CA, vol. 3.
9. Hunter K.S., Lee P.F., et al. Pulmonary vascular input impedance is a combined measure of pulmonary vascular resistance and stiffness and predicts clinical outcomes better than pulmonary vascular resistance alone in pediatric patients with pulmonary hypertension. American Heart Journal 2008, 155(1):166-174.
10. Kobs R.W., Chesler N.C. The mechanobiology of pulmonary vascular remodeling in the congenital absence of eNOS. Biomechanics and Modeling in Mechanobiolgy 2006, 5(4):217-225.
11. Kobs R.W., Muvarak N.E., et al. Linked mechanical and biological aspects of remodeling in mouse pulmonary arteries with hypoxia-induced hypertension. American Journal of Physiology Heart and Circulatory Physiology 2005, 288(3):H1209-1217.
12. Mahapatra S., Nishimura R.A., et al. The prognostic value of pulmonary vascular capacitance determined by Doppler echocardiography in patients with pulmonary arterial hypertension. Journal of the American Society of Echocardiography: Official Publication of the American Society of Echocardiography 2006, 19(8):1045-1050.
13. Milnor W.R. Hemodynamics 1989, Williams & Wilkins, Baltimore.
14. Milnor W.R., Conti C.R., et al. Pulmonary arterial pulse wave velocity and impedance in man. Circulation Research 1969, 25(6):637-649.
15. Mitchell G.F., Pfeffer M.A., et al. Measurement of aortic input impedance in rats. The American Journal of Physiology 1994, 267(5 Pt 2):H1907-1915.
16. Murray C.D. The physiological principle of minimum work applied to the angle of branching of arteries. Journal of General Physiology 1926, 9(6):835-841.
17. Ooi C.Y., Wang Z., et al. The role of collagen in extralobar pulmonary artery stiffening in response to hypoxia-induced pulmonary hypertension. American Journal of Physiology Heart and Circulatory Physiology 2010, 299(6):H1823-1831.
18. Pacher P., Nagayama T., et al. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nature Protocols 2008, 3(9):1422-1434.
19. Salerni R., Rodnan G.P., et al. Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma). Annals of Internal Medicine 1977, 86(4):394-399.
20. Saunders P.U., Pyne D.B., et al. Endurance training at altitude. High Altitude Medicine and Biology 2009, 10(2):135-148.
21. Silver R.M. Scleroderma. Clinical problems. The lungs. Rheumatic Diseases Clinics of North America 1996, 22(4):825-840.
22. Simonneau G., Galie N., et al. Clinical classification of pulmonary hypertension. Journal of the American College of Cardiology 2004, 43(12 Suppl S):5S-12S.
23. Stenmark K.R., Davie N., et al. Role of the adventitia in pulmonary vascular remodeling. Physiology (Bethesda, Md.) 2006, 21:134-145.
24. Stenmark K.R., Fagan K.A., et al. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circulation Research 2006, 99(7):675-691.
25. Stenmark K.R., Mecham R.P. Cellular and molecular mechanisms of pulmonary vascular remodeling. Annual Review of Physiology 1997, 59:89-144.
26. Tabima D.M., Chesler N.C. The effects of vasoactivity and hypoxic pulmonary hypertension on extralobar pulmonary artery biomechanics. Journal of Biomechanics 2010, 43(10):1864-1869.
27. Tabima D.M., Hacker T.A., et al. Measuring right ventricular function in the normal and hypertensive mouse hearts using admittance-derived pressure-volume loops. American Journal of Physiology Heart and Circulatory Physiology 2010.
28. Taylor, B.N. and C.E. Kuyatt (1994). Guidelines for evaluating and expressing the uncertainty of NIST measurement results.
29. Tuchscherer H.A., Vanderpool R.R., et al. Pulmonary vascular remodeling in isolated mouse lungs: effects on pulsatile pressure-flow relationships. Journal of Biomechanics 2007, 40(5):993-1001.
30. Vanderpool R.R., Kim A.R., et al. Effects of acute Rho kinase inhibition on chronic hypoxia-induced changes in proximal and distal pulmonary arterial structure and function. Journal of Applied Physiology 2011, 110(1):188-198.
31. Wang Z., Chesler N. Pulmonary vascular wall stiffness: an important contributor to the increased right ventricular afterload with pulmonary hypertension. Pulmonary Circulation 2011, 1:2.
32. Weissmann N., Hackemack S., et al. The soluble guanylate cyclase activator HMR1766 reverses hypoxia-induced experimental pulmonary hypertension in mice. American Journal of Physiology Lung Cellular and Molecular Physiology 2009, 297(4):L658-665.
33. Westerhof N., Sipkema P., et al. Forward and backward waves in the arterial system. Cardiovascular Research 1972, 6(6):648-656.
34. Woessner J.F. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Archives of Biochemistry and Biophysics 1961, 93:440-447.
35. Young R.H., Mark G.J. Pulmonary vascular changes in scleroderma. American Journal of Medicine 1978, 64(6):998-1004.